Biotronik AG
USPTO PatentsView assignee record - 116 granted patents across 43 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Biotronik ranks #3,221 of 49,997 tracked US assignees by granted-patent volume, with 116 patents across 43 technology areas.
- #3,221
- of 49,997 US assignees by volume
- Top 10%
- by Innovation Score (52.8/100)
- 14.1
- avg claims per patent
- +4%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R3221 · Foreign Corporation #3,221 · 116 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL
- GRANTS-MID 116 grants
- TOP-DECILE #3,221/49,997
- PHOTO-FINISH AMO Groningen B V
- CPC-WIDE A61F · 43 areas
- INNOV-PAR 52.8/100
- CLAIMS-RICH 14.1 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-FLAT +4% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: AMO Groningen B.V. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Biotronik’s 52.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Biotronik
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Biotronik · this assignee
Biotronik · this assignee
53 score
- Boehringer Ingelheim… · near
Boehringer Ingelheim… · near
53 score
- GD Energy Products · near
GD Energy Products · near
53 score
- Hatch · near
Hatch · near
53 score
- HCL America · near
HCL America · near
53 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Biotronik's Innovation Score is 52.8/100 (top 10% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Biotronik?
Each dot is one of Biotronik’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biotronik’s own 14.1 claims/patent is at or below the 14.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Biotronik's grants concentrate
Biotronik AG is a focused PatentsView assignee: 43 CPC subclasses with 56.9% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (16 grants) versus a trough of 8 in 2024. By volume, Biotronik sits between Yamada Manufacturing Co., Ltd. and Fujifilm Healthcare Corporation.
Biotronik's three-year grant acceleration
From 2019–2021 to 2022–2024, Biotronik AG moved from 41 to 29 grants (0.71x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,129. See the growth leaderboard.
Who files at Biotronik's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Yamada Manufactur…
Yamada Manufacturing Co., Ltd.
117 patents
- AMO Groningen B V
AMO Groningen B.V.
116 patents
- Angel Playing Car…
Angel Playing Cards Co., Ltd.
116 patents
- Arena Pharmaceuti…
Arena Pharmaceuticals, Inc.
116 patents
- Booz Allen Hamilt…
Booz Allen Hamilton Inc.
116 patents
- China Mobile Comm…
China Mobile Communication Co., Ltd Research Institute
116 patents
- DOW Tray
DOW Tray Co., Ltd.
116 patents
- Fujifilm Healthca…
Fujifilm Healthcare Corporation
116 patents
- Biotronik ◀
Biotronik AG
116 patents
What this shows Biotronik holds 116 patents at rank #3,221, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Biotronik
By rank, the assignees closest to #3,221 in granted patent volume.
- Yamada Manufacturing Co., Ltd. #3,217 · 117 patents
- AMO Groningen B.V. #3,218 · 116 patents
- Angel Playing Cards Co., Ltd. #3,219 · 116 patents
- Arena Pharmaceuticals, Inc. #3,220 · 116 patents
- Booz Allen Hamilton Inc. #3,222 · 116 patents
- China Mobile Communication Co., Ltd Research Institute #3,223 · 116 patents
- DOW Tray Co., Ltd. #3,224 · 116 patents
- Fujifilm Healthcare Corporation #3,225 · 116 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Biotronik's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Biotronik, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Biotronik ranks #89 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (53 here).
Similar claim depth
Nearest assignees by average claims per patent (14.1 here).
Biotronik's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
53 Top 10% higher than 90% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 10 | 8.6% |
| 2016 | 9 | 7.8% |
| 2017 | 9 | 7.8% |
| 2018 | 10 | 8.6% |
| 2019 | 15 | 12.9% |
| 2020 | 16 | 13.8% |
| 2021 | 10 | 8.6% |
| 2022 | 11 | 9.5% |
| 2023 | 10 | 8.6% |
| 2024 | 8 | 6.9% |
| 2025partial year | 8 | 6.9% |
Which technologies does Biotronik AG patent most?
Top 15 of 43 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Biotronik AG's patent record in context - here's where to go next.
- Biotronik AG's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 56.9% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #3,221 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Biotronik AG against Yamada Manufacturing Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 52.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.